Theragen Etex Co.Ltd (066700) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.020x

Based on the latest financial reports, Theragen Etex Co.Ltd (066700) has a cash flow conversion efficiency ratio of 0.020x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩3.08 Billion ≈ $2.09 Million USD) by net assets (₩152.04 Billion ≈ $103.03 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Theragen Etex Co.Ltd defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Theragen Etex Co.Ltd - Cash Flow Conversion Efficiency Trend (2008–2025)

This chart illustrates how Theragen Etex Co.Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Theragen Etex Co.Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Theragen Etex Co.Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Huneed Tech KO:005870	-0.006x
Bareket Capital Ltd TA:BRKT	N/A
Taekyung Chem KO:006890	0.014x
Liberty Shoes Limited NSE:LIBERTSHOE	0.117x
Francotyp-Postalia Holding AG F:FPH	0.005x
Sequana Medical NV BR:SEQUA	0.254x
B&B Triplewall Containers Limited NSE:BBTCL	0.198x
Victory Square Technologies Inc F:6F6	0.006x

Annual Cash Flow Conversion Efficiency for Theragen Etex Co.Ltd (2008–2025)

The table below shows the annual cash flow conversion efficiency of Theragen Etex Co.Ltd from 2008 to 2025. For the full company profile with market capitalisation and key ratios, see 066700 market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩159.17 Billion ≈ $107.87 Million	₩10.97 Billion ≈ $7.44 Million	0.069x	+403.28%
2024-12-31	₩130.54 Billion ≈ $88.47 Million	₩1.79 Billion ≈ $1.21 Million	0.014x	-82.72%
2023-12-31	₩152.93 Billion ≈ $103.64 Million	₩12.12 Billion ≈ $8.22 Million	0.079x	+18.67%
2022-12-31	₩143.60 Billion ≈ $97.31 Million	₩9.59 Billion ≈ $6.50 Million	0.067x	+271.32%
2021-12-31	₩222.70 Billion ≈ $150.92 Million	₩4.01 Billion ≈ $2.72 Million	0.018x	-49.11%
2020-12-31	₩374.12 Billion ≈ $253.54 Million	₩13.23 Billion ≈ $8.96 Million	0.035x	+12645.45%
2019-12-31	₩135.86 Billion ≈ $92.07 Million	₩37.69 Million ≈ $25.54K	0.000x	+100.12%
2018-12-31	₩80.92 Billion ≈ $54.84 Million	₩-18.58 Billion ≈ $-12.59 Million	-0.230x	-1223.09%
2017-12-31	₩86.93 Billion ≈ $58.91 Million	₩1.78 Billion ≈ $1.20 Million	0.020x	+117.59%
2016-12-31	₩72.10 Billion ≈ $48.86 Million	₩-8.38 Billion ≈ $-5.68 Million	-0.116x	-1825.75%
2015-12-31	₩68.82 Billion ≈ $46.64 Million	₩-415.37 Million ≈ $-281.49K	-0.006x	-1338.61%
2014-12-31	₩82.00 Billion ≈ $55.57 Million	₩39.95 Million ≈ $27.08K	0.000x	-99.59%
2008-12-31	₩26.20 Billion ≈ $17.76 Million	₩3.14 Billion ≈ $2.13 Million	0.120x	--

About Theragen Etex Co.Ltd

KQ:066700 Korea Pharmaceuticals

Market Cap

$47.81 Million

₩70.55 Billion KRW

Market Cap Rank

#22141 Global

#1363 in Korea

Share Price

₩2315.00

Change (1 day)

-3.94%

52-Week Range

₩2210.00 - ₩3315.00

All Time High

₩21800.00